免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

A Comprehensive Digital Care Program for Migraine Management

NCT:NCT07642414 · ENROLLING_BY_INVITATION

NCT IDNCT07642414
狀態ENROLLING_BY_INVITATION
開始日期2026-07-09
SponsorHinge Health, Inc (INDUSTRY)
First posted
Last updated

簡要摘要

This study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program combining an FDA-cleared neuromodulation wearable device (Enso), personalized exercise therapy, and a dedicated care team, in reducing migraine frequency among adults with episodic or chronic migraine.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑